• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检验二分类结局的群组随机试验中处理效应异质性的样本量要求。

Sample size requirements for testing treatment effect heterogeneity in cluster randomized trials with binary outcomes.

机构信息

Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.

Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Stat Med. 2023 Nov 30;42(27):5054-5083. doi: 10.1002/sim.9901. Epub 2023 Sep 14.

DOI:10.1002/sim.9901
PMID:37974475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10659142/
Abstract

Cluster randomized trials (CRTs) refer to a popular class of experiments in which randomization is carried out at the group level. While methods have been developed for planning CRTs to study the average treatment effect, and more recently, to study the heterogeneous treatment effect, the development for the latter objective has currently been limited to a continuous outcome. Despite the prevalence of binary outcomes in CRTs, determining the necessary sample size and statistical power for detecting differential treatment effects in CRTs with a binary outcome remain unclear. To address this methodological gap, we develop sample size procedures for testing treatment effect heterogeneity in two-level CRTs under a generalized linear mixed model. Closed-form sample size expressions are derived for a binary effect modifier, and in addition, a computationally efficient Monte Carlo approach is developed for a continuous effect modifier. Extensions to multiple effect modifiers are also discussed. We conduct simulations to examine the accuracy of the proposed sample size methods. We present several numerical illustrations to elucidate features of the proposed formulas and to compare our method to the approximate sample size calculation under a linear mixed model. Finally, we use data from the Strategies and Opportunities to Stop Colon Cancer in Priority Populations (STOP CRC) CRT to illustrate the proposed sample size procedure for testing treatment effect heterogeneity.

摘要

群组随机试验(CRTs)是一种流行的实验类型,其中随机化在群组水平上进行。虽然已经开发了用于规划 CRT 以研究平均治疗效果的方法,并且最近还开发了用于研究异质治疗效果的方法,但后者的目标开发目前仅限于连续结果。尽管 CRT 中存在二进制结果,但确定具有二进制结果的 CRT 中检测差异治疗效果所需的样本量和统计功效仍然不清楚。为了解决这一方法学差距,我们在广义线性混合模型下为两级 CRT 中的治疗效果异质性检验开发了样本量程序。为二进制效应修饰符推导出了闭式样本量表达式,此外,还为连续效应修饰符开发了一种计算效率高的蒙特卡罗方法。还讨论了对多个效应修饰符的扩展。我们进行模拟以检查拟议样本量方法的准确性。我们提出了几个数值说明,以阐明所提出公式的特征,并将我们的方法与线性混合模型下的近似样本量计算进行比较。最后,我们使用来自优先人群中的策略和机会停止结肠癌(STOP CRC)CRT 的数据来说明用于检验治疗效果异质性的建议样本量程序。

相似文献

1
Sample size requirements for testing treatment effect heterogeneity in cluster randomized trials with binary outcomes.检验二分类结局的群组随机试验中处理效应异质性的样本量要求。
Stat Med. 2023 Nov 30;42(27):5054-5083. doi: 10.1002/sim.9901. Epub 2023 Sep 14.
2
Sample size requirements for detecting treatment effect heterogeneity in cluster randomized trials.整群随机试验中检测治疗效果异质性的样本量要求。
Stat Med. 2020 Dec 10;39(28):4218-4237. doi: 10.1002/sim.8721. Epub 2020 Aug 21.
3
Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity.在设计用于检测治疗效果异质性的整群随机试验时,考虑不等的群组大小。
Stat Med. 2022 Apr 15;41(8):1376-1396. doi: 10.1002/sim.9283. Epub 2021 Dec 19.
4
Design and analysis of cluster randomized trials with time-to-event outcomes under the additive hazards mixed model.群组随机对照试验的设计与分析:在加性风险混合模型下的生存时间结局。
Stat Med. 2022 Oct 30;41(24):4860-4885. doi: 10.1002/sim.9541. Epub 2022 Jul 31.
5
An imbalance in cluster sizes does not lead to notable loss of power in cross-sectional, stepped-wedge cluster randomised trials with a continuous outcome.在具有连续结局的横断面、阶梯式整群随机试验中,整群大小的不平衡不会导致显著的效能损失。
Trials. 2017 Mar 7;18(1):109. doi: 10.1186/s13063-017-1832-8.
6
Comparing denominator degrees of freedom approximations for the generalized linear mixed model in analyzing binary outcome in small sample cluster-randomized trials.在小样本整群随机试验中分析二元结局时比较广义线性混合模型的分母自由度近似值。
BMC Med Res Methodol. 2015 Apr 23;15:38. doi: 10.1186/s12874-015-0026-x.
7
Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances.评估具有异质聚类相关系数和方差的随机试验中治疗效果异质性的样本量考虑。
Stat Med. 2023 Aug 30;42(19):3392-3412. doi: 10.1002/sim.9811. Epub 2023 Jun 14.
8
Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity.在规划评估治疗效果异质性的群组随机试验时,考虑预期的损耗。
BMC Med Res Methodol. 2023 Apr 6;23(1):85. doi: 10.1186/s12874-023-01887-8.
9
Sample size and power considerations for cluster randomized trials with count outcomes subject to right truncation.考虑到右截断的计数结局的群组随机试验的样本量和功效。
Biom J. 2021 Jun;63(5):1052-1071. doi: 10.1002/bimj.202000230. Epub 2021 Mar 10.
10
Sample size calculations for group randomized trials with unequal group sizes through Monte Carlo simulations.通过蒙特卡罗模拟对组间大小不等的群组随机试验进行样本量计算。
Stat Methods Med Res. 2018 Sep;27(9):2569-2580. doi: 10.1177/0962280216682775. Epub 2016 Dec 15.

引用本文的文献

1
Sample size and power calculation for testing treatment effect heterogeneity in cluster randomized crossover designs.用于检验群组随机交叉设计中治疗效果异质性的样本量和功效计算。
Stat Methods Med Res. 2024 Jul;33(7):1115-1136. doi: 10.1177/09622802241247736. Epub 2024 May 1.
2
Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials.在整群随机试验中存在效应修饰因素数据缺失的情况下评估治疗效果异质性。
Stat Methods Med Res. 2024 May;33(5):909-927. doi: 10.1177/09622802241242323. Epub 2024 Apr 3.

本文引用的文献

1
Estimating intra-cluster correlation coefficients for planning longitudinal cluster randomized trials: a tutorial.估算纵向群组随机试验的群组内相关系数:教程。
Int J Epidemiol. 2023 Oct 5;52(5):1634-1647. doi: 10.1093/ije/dyad062.
2
Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity.在规划评估治疗效果异质性的群组随机试验时,考虑预期的损耗。
BMC Med Res Methodol. 2023 Apr 6;23(1):85. doi: 10.1186/s12874-023-01887-8.
3
Designing three-level cluster randomized trials to assess treatment effect heterogeneity.设计三级整群随机临床试验评估治疗效果异质性。
Biostatistics. 2023 Oct 18;24(4):833-849. doi: 10.1093/biostatistics/kxac026.
4
Power analysis for cluster randomized trials with continuous coprimary endpoints.具有连续Coprimary 终点的群组随机试验的功效分析。
Biometrics. 2023 Jun;79(2):1293-1305. doi: 10.1111/biom.13692. Epub 2022 May 23.
5
Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity.在设计用于检测治疗效果异质性的整群随机试验时,考虑不等的群组大小。
Stat Med. 2022 Apr 15;41(8):1376-1396. doi: 10.1002/sim.9283. Epub 2021 Dec 19.
6
Sample size considerations for stepped wedge designs with subclusters.具有亚群组的阶乘楔形设计的样本量考虑。
Biometrics. 2023 Mar;79(1):98-112. doi: 10.1111/biom.13596. Epub 2021 Nov 16.
7
Association of intracluster correlation measures with outcome prevalence for binary outcomes in cluster randomised trials.群组随机试验中,二分类结局结局的簇内相关系数与结局发生率的关系。
Stat Methods Med Res. 2021 Aug;30(8):1988-2003. doi: 10.1177/09622802211026004. Epub 2021 Jul 4.
8
Intra-cluster correlations from the CLustered OUtcome Dataset bank to inform the design of longitudinal cluster trials.从聚类结局数据集银行获取的簇内相关性,为纵向聚类试验的设计提供信息。
Clin Trials. 2021 Oct;18(5):529-540. doi: 10.1177/17407745211020852. Epub 2021 Jun 4.
9
Sample size requirements for detecting treatment effect heterogeneity in cluster randomized trials.整群随机试验中检测治疗效果异质性的样本量要求。
Stat Med. 2020 Dec 10;39(28):4218-4237. doi: 10.1002/sim.8721. Epub 2020 Aug 21.
10
Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.通过邮寄粪便免疫化学检测试剂盒增加结直肠癌筛查效果的干预措施的调节因素:一项实用随机试验的结果。
Trials. 2020 Jan 15;21(1):91. doi: 10.1186/s13063-019-4027-7.